These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

946 related articles for article (PubMed ID: 32529568)

  • 1. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
    Feng Y; Wu H; Huang DQ; Xu C; Zheng H; Maeda M; Zhao X; Wang L; Xiao F; Lv H; Liu T; Qi J; Li J; Zhong N; Wang C; Feng H; Liang B; Ren W; Qin C; Nguyen MH; Zhu Q
    Eur Radiol; 2020 Nov; 30(11):6357-6368. PubMed ID: 32529568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study.
    Peng Z; Wei M; Chen S; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Kuang M
    Eur Radiol; 2018 Aug; 28(8):3522-3531. PubMed ID: 29536241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
    Bai XM; Cui M; Yang W; Wang H; Wang S; Zhang ZY; Wu W; Chen MH; Yan K; Goldberg SN
    Radiology; 2021 Aug; 300(2):458-469. PubMed ID: 34003058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeat hepatectomy versus radiofrequency ablation in management of recurrent hepatocellular carcinoma: an average treatment effect analysis.
    Chua DW; Koh YX; Syn NL; Chuan TY; Yao TJ; Lee SY; Goh BKP; Cheow PC; Chung AY; Chan CY
    Ann Surg Oncol; 2021 Nov; 28(12):7731-7740. PubMed ID: 33969464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiofrequency ablation versus surgical resection of hepatocellular carcinoma: contemporary treatment trends and outcomes from the United States National Cancer Database.
    Uhlig J; Sellers CM; Stein SM; Kim HS
    Eur Radiol; 2019 May; 29(5):2679-2689. PubMed ID: 30560364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined radiofrequency ablation and ethanol injection versus repeat hepatectomy for elderly patients with recurrent hepatocellular carcinoma after initial hepatic surgery.
    Chen S; Peng Z; Xiao H; Lin M; Chen Z; Jiang C; Hu W; Xie X; Liu L; Peng B; Kuang M
    Int J Hyperthermia; 2018 Nov; 34(7):1029-1037. PubMed ID: 28974113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.
    Lee S; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim JM; Kim K
    J Hepatol; 2018 Jul; 69(1):70-78. PubMed ID: 29524532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis.
    Li YC; Chen PH; Yeh JH; Hsiao P; Lo GH; Tan T; Cheng PN; Lin HY; Chen YS; Hsieh KC; Hsieh PM; Lin CW
    BMC Gastroenterol; 2021 Nov; 21(1):418. PubMed ID: 34749663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver resection versus radiofrequency ablation for recurrent hepatocellular carcinoma: a systematic review and meta-analysis.
    Yang Y; Yu H; Tan X; You Y; Liu F; Zhao T; Qi J; Li J; Feng Y; Zhu Q
    Int J Hyperthermia; 2021; 38(1):875-886. PubMed ID: 34078221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency ablation versus resection for the treatment of early stage hepatocellular carcinoma: a multicenter Australian study.
    Gory I; Fink M; Bell S; Gow P; Nicoll A; Knight V; Dev A; Rode A; Bailey M; Cheung W; Kemp W; Roberts SK;
    Scand J Gastroenterol; 2015 May; 50(5):567-76. PubMed ID: 25615260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical Resection Versus Radiofrequency Ablation for Single Hepatocellular Carcinoma ≤ 2  cm in a Propensity Score Model.
    Liu PH; Hsu CY; Hsia CY; Lee YH; Huang YH; Chiou YY; Lin HC; Huo TI
    Ann Surg; 2016 Mar; 263(3):538-45. PubMed ID: 25775062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk factors for long-term survival outcome in solitary hepatocellular carcinoma up to 2 cm: Propensity score matching analysis in a population cohort with a high rate of HBV infection.
    Wang G; Zhang W; Tan Y; Jiang L; Yang J; Yang J; Yan L
    Int J Surg; 2019 Dec; 72():1-6. PubMed ID: 31610283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimally invasive surgery versus radiofrequency ablation for single subcapsular hepatocellular carcinoma ≤ 2 cm with compensated liver cirrhosis.
    Lin CH; Ho CM; Wu CH; Liang PC; Wu YM; Hu RH; Lee PH; Ho MC
    Surg Endosc; 2020 Dec; 34(12):5566-5573. PubMed ID: 31993821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency ablation versus repeat hepatectomy in the treatment of recurrent hepatocellular carcinoma in subcapsular location: a retrospective cohort study.
    Wei F; Huang Q; Zhou Y; Luo L; Zeng Y
    World J Surg Oncol; 2021 Jun; 19(1):175. PubMed ID: 34127007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival analysis of re-resection versus radiofrequency ablation for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma.
    Chan AC; Poon RT; Cheung TT; Chok KS; Chan SC; Fan ST; Lo CM
    World J Surg; 2012 Jan; 36(1):151-6. PubMed ID: 22030561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of radiofrequency ablation for initial recurrent hepatocellular carcinoma after curative treatment: Comparison with primary cases.
    Fukuhara T; Aikata H; Hyogo H; Honda Y; Morio K; Morio R; Hatooka M; Kobayashi T; Naeshiro N; Kawaoka T; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Chayama K
    Eur J Radiol; 2015 Aug; 84(8):1540-1545. PubMed ID: 25979193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined image-guided radiofrequency and iodine-125 seeds implantation in the treatment of recurrent hepatocellular carcinoma after hepatectomy.
    Cao F; Zheng J; Hao W
    BMC Cancer; 2024 May; 24(1):666. PubMed ID: 38822264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment optimization for recurrent hepatocellular carcinoma: Repeat hepatic resection versus radiofrequency ablation.
    Lu LH; Mei J; Kan A; Ling YH; Li SH; Wei W; Chen MS; Zhang YF; Guo RP
    Cancer Med; 2020 May; 9(9):2997-3005. PubMed ID: 32108433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sorafenib as adjuvant therapy following radiofrequency ablation for recurrent hepatocellular carcinoma within Milan criteria: a multicenter analysis.
    Zhou Q; Wang X; Li R; Wang C; Wang J; Xie X; Li Y; Li S; Mao X; Liang P
    J Gastroenterol; 2022 Sep; 57(9):684-694. PubMed ID: 35816221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of adjuvant transcatheter arterial chemoembolization following repeated curative resection/ablation for hepatocellular carcinoma with early recurrence: a propensity score matching analysis.
    Huang K; Qian T; Chen W; Lao M; Li H; Lin WC; Chen BW; Bai X; Gao S; Ma T; Liang T
    BMC Cancer; 2024 May; 24(1):620. PubMed ID: 38773564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.